Where: Marshall McLuhan Hall, University of Manitoba
Kickoff – Commercialization Journey |
||
8:30 – 9:00 am | Coffee/tea, light breakfast | |
9:00 – 9:10 am | Welcome remarks | |
9:10 – 9:40 am | Plenary – with Dr. Mark Evans, President & CEO, Conquest Planning Inc.
Hear from a respected entrepreneur, philanthropist, and educator who, while a faculty member in the UM Department of Computer Science, developed a corporation which became the largest international supplier of software solutions to financial planners. |
|
Protecting Your IP and the Path Ahead |
||
9:40 – 10:05 am | Patents – with Silvia de Sousa, Intellectual Property Lawyer , Thompson Dorfman Sweatman Law and Dr. Mike Williams, Registered Patent Agent, Ade & Company Inc.
Learn how to ensure your research IP is properly protected and maximized, and discover what you need to know about the patent process from the experts. |
|
10:05 – 10:30 am |
Startup or Licensing – with Marshall Ring, CEO, Manitoba Technology Accelerator Determine the best path for your research– start-up or licensing – and learn how to assess the market and development pathway, and raise venture capital. |
|
10:30 – 10:45 am | Coffee Break | |
Mentored Concept Development (For NEW funding opportunity: Faculty of Science Research Innovation and Commercialization Grant) |
||
10:45 – 11:50 am | Mentored Concept Development Consultations
Expert review and feedback on your concept from relevant experts, intended for faculty members interested in applying to Faculty of Science Research Innovation and Commercialization Grant, with the purpose of supporting and enhancing concept/proposal development for funding opportunities of up to 10K per idea. |
|
11:50 – 12:45 pm | Networking Lunch | |
12:45 – 1:15 pm | Mentored Concept Development Consultations Wrap-up: next steps and action items | |
1:15 – 1:30 pm | Coffee Break | |
Speaker, IP Info Session and Expert Panel |
||
1:30– 1:50 pm | All Graduate Students welcome
Seeds of Transformation: The importance of commercializing great ideas to create the world we want to live in – with Dr. Andrea Kraj, CEO, Core Renewable Energy Gain insight from a Canadian entrepreneur, award-winning speaker, and influencer. |
|
1:50 – 2:20 pm | Protecting your IP and Assessing Commercial Potential of Research – with Dr. Darren Fast, Director, Technology Transfer Office, University of Manitoba.
Learn more about protecting your IP and assessing the commercial potential of your research. |
|
2:20 – 3:10 pm | Expert Panel
Curious about IP, patents, entrepreneurship and commercializing? Don’t ask us – get advice and solutions from the experts. Q&A – facilitated by Joel Semeniuk, Founder and CEO of HORIZONthree. Our expert panel includes: Dr. Mark Evans, President & CEO, Conquest Planning Inc. Silvia de Sousa – IP Lawyer, Thompson Dorfman Sweatman Law Dr. Mike Williams – Registered Patent Agent, Ade & Company Inc Marshall Ring, CEO, Manitoba Technology Accelerator Dr. Andrea Kraj – CEO, Core Renewable Energy Dr. Darren Fast – Director, Transfer Technology Office, University of Manitoba Dr. Stasi Baran – Co-founder and COO, nQube Data Science Inc. |
|
Keynote and Reception |
||
3:30 – 4:30 pm |
From researcher to founder of leading medical imaging companyDr. Rick Mangat While carrying out research at the University of Manitoba for his PhD thesis in Pharmacology, Dr. Rick Mangat co-invented the SPY Imaging System – a product that can be used in surgeries to assess blood flow and perfusion thereby impacting the lives of patients and doctors across the world. Through this, Dr. Mangat co-founded NOVADAQ Technologies Inc. in 2000 and has held numerous positions within the company including the role of CEO from 2000-2003 and from 2016 until the company was sold in September 2017. Under Dr. Mangat’s leadership, NOVADAQ Technologies Inc. became a pioneer in facilitating medical professionals with relevant, point of care imaging solutions that enhance the lives of patients and their caregivers. SPY Technology has been used to conduct over 260,000 procedures, it has been documented as being valuable in over 75 different surgical applications, and has been featured in over 260 peer reviewed publications for its innovative contribution to complex surgeries and diagnostic procedures. In September 2017 Novadaq was acquired by Stryker Corporation for approximately $1 billion Canadian which made the sale the largest medical device company sale in Canada to date. Where: Robert Schultz Lecture Theater, St. John’s College 91 Ralph Campbell Way Surgeons using NOVADAQ’s technology
|
|
4:30 pm |
Refreshments |